Despite the few studies linking leptin to the progression of lung cancer, it has been reported that the polymorphism of the leptin gene LEP-2548 G/A increases the susceptibility to the development of non-small-cell lung cancer (NSCLC), which represents 75–80% of lung cancer [172]. Here, LEP is linked to non-small cell lung carcinoma.